首页> 美国政府科技报告 >Evaluation of a Briquet Formulation of Bacillus thuringiensis var. israelensis (H-14) against Aedes spp. and Culex spp. Larvae in Dambos in Kenya
【24h】

Evaluation of a Briquet Formulation of Bacillus thuringiensis var. israelensis (H-14) against Aedes spp. and Culex spp. Larvae in Dambos in Kenya

机译:苏云金芽孢杆菌(Bacillus thuringiensis var。)的压块配方评价。 israelensis(H-14)对抗伊蚊属。和库蚊肯尼亚Dambos的幼虫

获取原文

摘要

Bacillus thuringiensis Berliner var. israelensis serotype H-14 (Bti) in briquetformulation (Bactimos) was tested in a field trial against ground-pool breeding mosquitoes in a dambo located in a Rift Valley fever virus-enzootic/epizootic area in central Kenya. Bactimos (10% Bti; 7000 AA International Toxic Units/mg) was tested for 30 days in 3 separate treatment areas at the rate of 1 briquet/9 m2, later increased to 1 briquet/1.5 m2 on day 13 postflood; 1 briquet/9 m2; and 1 briquet(4.6 m2). An estimate of the daily survival rate of larvae at different periods during the study revealed that mosquitoes in the area treated with 1 briquet/9 m 2 had a significantly lower (64%) survival rate than those in the control site (92 %) against Aedes spp. and was not significantly different from the site treated with 1 briquet/4.6 m 2. Mosquitoes in the site treated with 1 briquet/1.5 m 2 on day 13 postflood had a much-reduced survival rate (25%) when compared to those in the control site (67%) during the 3rd Culex spp. generation (22 -26 days postflood). This five-fold increase above standard label dosage still failed to prevent Culex spp. emergence. There was no significant difference in survival rates between the control and any of the three treatment sites during

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号